Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bilastine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Optimized preparation of Bilastine via stable carboxylic acid intermediates. Avoids ether cleavage impurities. Ideal for reliable API supplier partnerships.
Novel palladium-catalyzed route for bilastine intermediates ensures high yield and safety. Reliable supplier for pharmaceutical manufacturing cost reduction.
Novel patent CN106146459A details cost-effective Bilastine production using 2-nitroaniline ensuring high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN106146459A reveals a cost-effective Bilastine synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN112110811B details a novel Pd-catalyzed route for bilastine intermediates, offering high purity and scalable manufacturing for global supply chains.
Patent CN103214455A reveals a mild hypochlorite oxidation route for Bilastine, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel nickel-catalyzed route for Bilastine key intermediate reduces toxicity and cost, offering a scalable supply chain solution for global pharmaceutical manufacturers.
Novel synthesis route for Bilastine avoids toxic reagents. High yield, cost-effective manufacturing for pharmaceutical supply chains.
Novel patent CN104177331A offers high-purity Bilastine intermediate synthesis with reduced toxicity and improved yield for pharmaceutical manufacturing.
Novel 3-step route for bilastine intermediate via Pd-catalysis. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN110803985A discloses a safe, scalable synthesis of Bilastine intermediate II using vinyl sulfate, avoiding toxic ethylene oxide and expensive noble metal catalysts.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Discover a cost-effective bilastine synthesis method with 40-45% total yield, eliminating hazardous reagents and complex purification. Ideal for API manufacturing.
Discover a cost-efficient bilastine synthesis method with 40-45% total yield and >99.5% purity, eliminating hazardous reagents and complex steps for seamless scale-up.